Global Pharmaceutical Drug Delivery Market Expected to Reach USD 2,205.5 Billion by 2033 - IMARC Group

December 04, 2024 | Healthcare

VIEW FULL TABLE OF CONTENTS

Global Pharmaceutical Drug Delivery Market Statistics, Outlook and Regional Analysis 2025-2033

The global pharmaceutical drug delivery market size was valued at USD 1,465.2 Billion in 2024, and it is expected to reach USD 2,205.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.6% from 2025 to 2033.

Pharmaceutical Drug Delivery Market

To get more information on this market, Request Sample

At present, the rising number of patients suffering from chronic conditions, such as diabetes, cancer, and cardiovascular diseases, is driving the demand for advanced drug delivery systems to ensure effective treatment and improved quality of life. Additionally, increasing preferences for non-invasive methods such as oral, nasal, and transdermal drug delivery, due to their convenience, patient compliance, and reduced risk of complications compared to traditional injectable routes is bolstering the market growth. In 2024, Dong-A ST launched the Growtropin-II Inj. I Pen, a user-friendly growth hormone pen for conditions like GHD and ISS, featuring precise dosing and room-temperature usability for up to 10 days. This innovation aligns with the rapidly growing pediatric growth hormone market in Korea.

In addition, the rising incorporation of digital health tools, including smart drug delivery systems with real-time monitoring capabilities, is enhancing treatment outcomes. Furthermore, the increasing emphasis on precision medicine is facilitating the development of drug delivery systems that target specific cells or tissues, ensuring higher efficacy and minimal side effects. Besides this, the growing approval and launch of generic and specialized drug delivery systems are offering a favorable market outlook. These systems improve the efficiency of treatment, reduce possible side effects, and promote patient compliance. Businesses also are targeting product expansion lines with innovative new offerings to meet healthcare needs. In 2024, ANI Pharmaceuticals obtained FDA authorization and released Naproxen Delayed-Release Tablets, USP, which is a generic alternative to EC-Naprosyn®. This delayed-release NSAID aims for a $36.7 million US market by providing controlled drug release to reduce gastrointestinal side effects. The introduction enhances ANI's range of generic products and is in line with its plan for expansion. It emphasizes the company's dedication to offering pharmaceutical solutions that are high-quality and easily accessible.

Global Pharmaceutical Drug Delivery Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share due to its advanced healthcare infrastructure, high adoption of innovative drug delivery technologies, and the growing prevalence of chronic diseases requiring specialized treatment solutions.

North America Pharmaceutical Drug Delivery Market Trends:

North America is the leading market for pharmaceutical drug delivery due to its advanced healthcare systems and emphasis on research and innovation. The region has an advanced uptake of advanced drug delivery systems such as wearables and biologics. Increased healthcare investment, along with the growing importance of personalization in medicines. Pharmaceutical companies keep collaborating with technology providers to advance their market positions further, maintaining drug delivery innovations in North America. In 2024, Eli Lilly released a new vial version of its weight-loss drug Zepbound in the US. It is sold at $399 and $549 for a four-week supply, which is roughly half the price of its injector pen. This is aimed at further improving efficiency in manufacturing, extending more patients, and eliminating peak demand in light of a constrained supply.

Asia-Pacific Pharmaceutical Drug Delivery Market Trends:

The Asia Pacific region is witnessing growth in the pharmaceutical drug delivery market, driven by increasing healthcare access and rising awareness about advanced treatment options. The growing population with chronic diseases is driving the need for new delivery systems. The continued development of technology and government support are increasing the use of contemporary healthcare solutions. Furthermore, the area is profiting from efficient manufacturing and a strong pharmaceutical sector, positioning it as an appealing center for investments in drug delivery technologies.

Europe Pharmaceutical Drug Delivery Market Trends:

The pharmaceutical drug delivery market of Europe is growing because the region boasts a robust infrastructure for healthcare and continued advancements in the techniques of delivery. The market is being expanded through development and research into patient-friendly choices, including non-invasive techniques and controlled release systems. There is increased financing for research projects that now provide opportunities for innovative therapeutic remedies. Lastly, the growing percentage of older populations and higher cases of chronic diseases have increased the demands for targeted drug delivery.

Latin America Pharmaceutical Drug Delivery Market Trends:

Latin America's pharmaceutical drug delivery industry is expanding due to advancing innovative treatment techniques and better health-care infrastructure. The rising consciousness of advanced drug delivery techniques is boosting adoption in this region. Favorable policies and a developing pharmaceutical sector contribute to the region's momentum in adopting innovative drug delivery solutions.

Middle East and Africa Pharmaceutical Drug Delivery Market Trends:

The Middle East and Africa are witnessing growth in the pharmaceutical drug delivery market because of the increasing focus on upgrading health access and infrastructure. The increase in demand for advanced treatments drives the adoption of innovative drug delivery systems. Growing awareness among people regarding modern healthcare solutions also influences the market growth positively.

Top Companies Leading in the Pharmaceutical Drug Delivery Industry

Some of the leading pharmaceutical drug delivery market companies include AbbVie Inc., Amgen Inc., AstraZeneca plc, Becton Dickinson and Company, Eli Lilly and Company, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A among many others. In April 2024, Medincell and AbbVie Inc agreed to work together to develop as many as six extended-release injectable medications, utilizing Medincell's slow-release drug delivery technology. The agreement, valued at $1.9 billion, consists of development milestones, royalties, and commercialization to be done by AbbVie. This partnership comes after Medincell's approval by the FDA for Uzedy, Teva's extended-release schizophrenia medication.

Global Pharmaceutical Drug Delivery Market Segmentation Coverage

On the basis of the route of administration, the market has been categorized into oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, implantable drug delivery, transmucosal drug delivery, and nasal drug delivery, wherein oral drug delivery represents the leading segment. Oral drug delivery leads the market because of its simplicity, non-invasive nature, and strong patient compliance. The complexity of the formulation, which includes targeted delivery and controlled-release systems, also enhances its effectiveness. Advances in oral drug delivery methods continue to become the preferred choice of patients and healthcare professionals for various therapeutic applications.
Based on the application, the market is classified into infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and others, amongst which cancer dominates the market. Cancer represents the largest segment attributed to the growing cases of the disease and the rising need for sophisticated and targeted therapies. New techniques for medication delivery like implantable devices and nanoparticles decrease the side effects and increase the treatment effectiveness. In addition, more funds for cancer research, increasing demand for personalized medicines also fuel the demand for efficient drug delivery systems that have been specifically developed for cancer.
On the basis of the end user, the market has been divided into hospitals, ambulatory surgery centers, home care settings, diagnostic centers, and others. Among these, hospitals account for the majority of the market share. Hospitals lead the market due to their advanced facilities and ability to provide extensive care. They are trained to manage intricate drug administration methods like injectables and implantable delivery systems, guaranteeing best outcomes for patients. Moreover, the increasing cases of chronic conditions worldwide and the rise in inpatient admissions is strengthening the market growth.

Report Features	Details
Market Size in 2024	USD 1,465.2 Billion
Market Forecast in 2033	USD 2,205.5 Billion
Market Growth Rate 2025-2033	4.6%
Units	Billion USD
Scope of the Report	Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: Route of Administration Application End User Region
Routes of Administrations Covered	Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery, Nasal Drug Delivery
Applications Covered	Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Others
End Users Covered	Hospitals, Ambulatory Surgery Centers, Home Care Settings, Diagnostic Centers, Others
Regions Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	AbbVie Inc., Amgen Inc., AstraZeneca plc, Becton Dickinson and Company, Eli Lilly and Company, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A., etc.
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Browse IMARC Related Reports on Pharmaceutical Drug Delivery Market:

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Global Pharmaceutical Drug Delivery Market Expected to Reach USD 2,205.5 Billion by 2033 - IMARC Group

Purchase Options New Year Sale

Inquire Before Buying

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.